Navigation Links
Bluechiip Receives First Sales Order from ATCC after Completion of Successful Pilot Trial
Date:6/21/2012

MELBOURNE, Australia, June 21, 2012 /PRNewswire-Asia/ -- Bluechiip Limited (ASX: BCT) - which has developed a unique asset-tracking solution initially for cryogenic sample management in the healthcare and life science industry - today announced that a successful pilot trial of its tracking solution by ATCC (www.atcc.org), a US-based leader in biological materials management and processes, has led to the first sales order for Bluechiip's products from ATCC.

ATCC is purchasing the bluechiip® solution so that they may be an early adopter of the bluechiip® technology and to facilitate enhancement of cryogenic sample management and bench research via temperature evaluation and tracking.

ATCC stores approximately 10 million biological samples of different formats. The repository portion of its facility contains 200 freezers to store biomaterials, including vapor-phase liquid nitrogen freezers, mechanical freezers and cold rooms. End users of these products and services originate from over 140 countries and include researchers in academia and government, as well as private industry. ATCC's collections encompass a wide range of biological materials for research, including but not limited to cell lines, microorganisms and bioproducts.

The pilot trial was a collaboration sponsored by Bluechiip, ATCC and Corning Life Sciences. The robust study was conducted at ATCC's biological resource facility in Manassas, Virginia. The pilot trial evaluated the bluechiip® technology across a comprehensive range of cryogenic sample management and cold chain processes. The pilot trial verified the bluechiip® tracking solution - which enables sample identification and temperature information to be read at temperatures as low as those reached in liquid nitrogen, approximately -196 degrees Celsius and enables data to be transmitted through frost.

Bluechiip's Managing Director, Brett Schwarz, said: "We are excited to receive our first sales order, particularly from a world leader in our first targeted market of biobanking and biorepositories. This is validation of the enormous potential and wideranging applications of the bluechiip® tracking solution."

Kathleen Wyatt, Manager, Inventory Control and Respository Operations, ATCC, said, "ATCC has a long history of exploring inventive and forward-thinking technologies in biological materials management. Bluechiip is elevating cold chain custody and temperature tracking to an exciting new level. This endeavour with Bluechiip has the potential to enhance future offerings by ATCC."

About Bluechiip Limited:Bluechiip has developed a wireless tracking solution with temperature sensing capabilities for the healthcare and life science, security, defence and manufacturing industries which represents a generational change from current methods such as labels (hand-written and pre-printed), barcodes (linear and 2D) and microelectronic integrated circuit (IC)-based RFID (Radio Frequency Identification).

The unique tag is based on MEMS technology and contains no electronics. The tag can either be embedded or manufactured into a storage product, such as vials or bags. Easy identification, along with any associated information from the tag such as temperature can be detected by a reader, which can also sense the temperature of the tagged items. The traditional identification technologies have significant limitations. Whereas a barcode requires a visible tag or line-of-sight optical scan, bluechiip® technology does not. Unlike labels, barcodes and RFID, the bluechiip® technology can sense the temperature of each item a tag is attached to, or embedded in.

The bluechiip® technology has initial applications in the healthcare industry particularly those businesses which require cryogenic storage facilities (biobanks and biorepositories). bluechiip® offers the only technology that enables accurate and reliable tracking of products including stem cells, cord blood, and other biospecimens. In addition to functioning in extreme temperatures, the bluechiip® tracking solution can survive autoclaving, gamma irradiation sterilization, humidification, centrifuging, cryogenic storage and frosting. The bluechiip® technology has other healthcare applications in pathology, clinical trials and forensics. Several other key markets outside of healthcare include coldchain logistics/supply chain, security/defence, industrial/manufacturing and aerospace/aviation.

Further information is available at www.bluechiip.comFor more information:Brett Schwarz

Richard AllenManaging Director, Bluechiip Limited

Oxygen Financial Public RelationsPh: +61-419-367-590

Ph: +61-3-9915-6341brett.schwarz@bluechiip.com

richard@oxygenpr.com.au  


'/>"/>
SOURCE Bluechiip Limited
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. PAREXEL Chief Operating Officer Dr. Mark A. Goldberg Receives Special Recognition Award
2. Leica Biosystems Receives FDA Approval for the Fully Automated Bond Oracle™ HER2 IHC System on the Leica BOND-MAX
3. Nephros Receives 510(k) Clearance for Hemodiafiltration System
4. ProUroCare Medical Receives FDA Clearance for ProUroScan Elasticity Imaging System
5. BONESUPPORT Receives Red Herring 2012 Top 100 Europe Award
6. Diabecline Antibiotic Receives Edison Award for Best New Pharmaceutical Product
7. Lexicon Receives Funding for Phase 2 Clinical Trial of LX4211 in Type 1 Diabetes
8. Alexza Receives Complete Response Letter for Adasuve™ NDA
9. Ventana Receives FDA Clearance for p53 (DO-7) Image Analysis and Digital Read Applications
10. Marshall Edwards Receives $4 Million Subscription From Novogen In Rights Offering
11. New Chronic Wound Treatment Device Receives Award from Veterans Healthcare Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... Pa. , Oct. 12, 2017 ... leader in innovative solutions for injectable drug administration, today ... before the market opens on Thursday, October 26, 2017, ... the results and business expectations at 9:00 a.m. Eastern ... (U.S.) or 253-336-8738 (International). The conference ID is 94093362. ...
(Date:10/11/2017)...  Hill-Rom Holdings, Inc. ("Hill-Rom") (NYSE: HRC), today provided ... Piedras, Puerto Rico , where the ... Following a comprehensive onsite ... structural damage, temporary loss of power and minimal water ... manufacturing operations have resumed, and the company expects to ...
(Date:10/5/2017)... ROSEMONT, Ill. , Oct. 5, 2017 /PRNewswire-USNewswire/ ... American Association of Oral and Maxillofacial Surgeons (AAOMS) ... than opioids – to be used as a ... post-surgical pain. ... relationship, the AAOMS White Paper "Opioid Prescribing: Acute ...
Breaking Medicine Technology:
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... Ellevate Network, ... in business to advocate for action towards gender equality at their inaugural Summit in ... around the globe, and reached a social audience of over 3 million. To watch ...
(Date:10/13/2017)... ... ... “The Journey: From the Mountains to the Mission Field”: the story of ... Philippines. “The Journey: From the Mountains to the Mission Field” is the creation of ... taught all ages and currently teaches a class of ladies at her church, which ...
(Date:10/12/2017)... ... October 12, 2017 , ... The company has ... today’s consumer and regulatory authorities worldwide. From Children’s to Adults 50+, every formula ... the highest standard. , These products are also: Gluten Free, Non-GMO, Vegan, ...
(Date:10/12/2017)... ... October 12, 2017 , ... Dr. Parsa Mohebi, the Los ... article to the newly revamped Cosmetic Town journal section, featuring articles ... procedure known as Follicular Unit Extraction (FUE). , Dr. Mohebi says ...
(Date:10/12/2017)... ... 2017 , ... Health Literacy Innovations (HLI), creator of the ... the Cancer Patient Education Network (CPEN), an independent professional organization that shares best ... alliance. , As CPEN’s strategic partner, HLI will help support CPEN members ...
Breaking Medicine News(10 mins):